Advertisement

U.S. Stops Funding for Gavi Global Vaccine Program, Sparking Backlash

0
By I. Edwards HealthDay Reporter FRIDAY, June 27, 2025 (HealthDay News) — The United States will stop sending money to Gavi, a global group that...

RFK Jr.-Appointed Vaccine Panel Removes Flu Shot Ingredient

0
By I. Edwards HealthDay Reporter FRIDAY, June 27, 2025 (HealthDay News) — A U.S. vaccine advisory panel voted Thursday to stop recommending flu shots that...

COVID Vaccine Labels to Warn of Rare Heart Risk

0
By I. Edwards HealthDay Reporter FRIDAY, June 27, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has added new warnings to the...

27.2 Million People of All Ages Uninsured in 2024 in the United States

0

Nonsignificant increase seen from 2023; 11.6 percent of adults aged 18 to 64 and 5.1 percent of children aged 0 to 17 were uninsured in 2024

Two-Hour Observation Probably Safe for Most Children With Anaphylaxis

0

95.3 percent of children who present to ER with acute anaphylaxis would have been safely discharged two hours after first epinephrine dose

Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction

0

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function

CDC Pulls Vaccine Slide After Expert Cites Study Doesn’t Exist

0
By I. Edwards HealthDay Reporter THURSDAY, June 26, 2025 (HealthDay News) — A presentation scheduled for a U.S. Centers for Disease Control and Prevention (CDC)...

Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile

0

Clinical cure and no disease recurrence within 60 days for 66.7 percent in FMT group, 61.2 percent in vancomycin group

ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes

0

All three doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40

Desogestrel for More Than Five Years May Up Risk of Intracranial Meningioma

0

Small increased risk seen for women who have used desogestrel 75 µg for more than five continuous years